HRP950446A2 - Substituted quinoline derivatives, process for their preparation and their use - Google Patents

Substituted quinoline derivatives, process for their preparation and their use Download PDF

Info

Publication number
HRP950446A2
HRP950446A2 HRP4428932.4A HRP950446A HRP950446A2 HR P950446 A2 HRP950446 A2 HR P950446A2 HR P950446 A HRP950446 A HR P950446A HR P950446 A2 HRP950446 A2 HR P950446A2
Authority
HR
Croatia
Prior art keywords
fluorine
chlorine
hydroxyl
optionally substituted
alkoxyl
Prior art date
Application number
HRP4428932.4A
Other languages
English (en)
Croatian (hr)
Inventor
Reinhard Kirsch
Joerg-Peter Kleim
Guenther Riess
Manfred Roesner
Irvin Winkler
Original Assignee
Hoechst Ag
Ruhrchemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Ruhrchemie Ag filed Critical Hoechst Ag
Publication of HRP950446A2 publication Critical patent/HRP950446A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP4428932.4A 1994-08-16 1995-08-10 Substituted quinoline derivatives, process for their preparation and their use HRP950446A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4428932A DE4428932A1 (de) 1994-08-16 1994-08-16 Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
HRP950446A2 true HRP950446A2 (en) 1997-08-31

Family

ID=6525747

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP4428932.4A HRP950446A2 (en) 1994-08-16 1995-08-10 Substituted quinoline derivatives, process for their preparation and their use

Country Status (24)

Country Link
US (1) US5798365A (fr)
EP (1) EP0697405B1 (fr)
JP (1) JP3860618B2 (fr)
KR (1) KR960007567A (fr)
CN (1) CN1123275A (fr)
AT (1) ATE222239T1 (fr)
AU (1) AU710238B2 (fr)
CA (1) CA2156128A1 (fr)
CZ (1) CZ209095A3 (fr)
DE (2) DE4428932A1 (fr)
DK (1) DK0697405T3 (fr)
ES (1) ES2179857T3 (fr)
FI (1) FI953841A7 (fr)
HR (1) HRP950446A2 (fr)
HU (1) HUT73133A (fr)
IL (1) IL114937A0 (fr)
NO (1) NO306296B1 (fr)
NZ (1) NZ272730A (fr)
PL (1) PL310030A1 (fr)
PT (1) PT697405E (fr)
SI (1) SI9500260A (fr)
SK (1) SK100695A3 (fr)
TW (1) TW407151B (fr)
ZA (1) ZA956798B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7397363B2 (en) * 1993-06-08 2008-07-08 Raymond Anthony Joao Control and/or monitoring apparatus and method
US6658833B2 (en) * 2000-11-09 2003-12-09 Bestrake, Llc Collector and separator apparatus for lawn and garden
US7576094B2 (en) * 2004-12-13 2009-08-18 Eli Lilly And Company Spiro derivatives as lipoxygenase inhibitors
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
PH12013500015A1 (en) 2010-07-02 2013-02-18 Gilead Sciences Inc 2 -quinolinyl- acetic acid derivatives as hiv antiviral compounds
AP2013006706A0 (en) 2010-07-02 2013-02-28 Gilead Sciences Inc Napht-2-ylacetic acid derivatives to treat AIDS
UA111841C2 (uk) 2011-04-21 2016-06-24 Гіліад Сайєнсіз, Інк. Сполуки бензотіазолу та їх фармацевтичне застосування
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
WO2013103738A1 (fr) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Dérivés d'acide naphtalène acétique contre l'infection par le vih
US9096586B2 (en) 2012-04-20 2015-08-04 Gilead Sciences, Inc. Therapeutic compounds
JP2025500506A (ja) * 2021-12-23 2025-01-09 ザ・カトリック・ユニヴェルシテイト・ルーバン Ｙａｐ／ｔａｚ－ｔｅａｄを阻害するためのスピロ及び関連類似体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0579695A1 (fr) * 1991-03-14 1994-01-26 The Upjohn Company Composes reissert utilises comme agents anti-hiv
DE4142322A1 (de) * 1991-12-20 1993-07-01 Hoechst Ag Chinoxaline, verfahren zu ihrer herstellung und ihreverwendung
TW304945B (fr) * 1992-06-27 1997-05-11 Hoechst Ag

Also Published As

Publication number Publication date
HUT73133A (en) 1996-06-28
EP0697405B1 (fr) 2002-08-14
DE4428932A1 (de) 1996-02-22
FI953841A0 (fi) 1995-08-14
KR960007567A (ko) 1996-03-22
AU2853195A (en) 1996-02-29
CN1123275A (zh) 1996-05-29
CA2156128A1 (fr) 1996-02-17
NZ272730A (en) 1998-01-26
US5798365A (en) 1998-08-25
HU9502403D0 (en) 1995-10-30
EP0697405A1 (fr) 1996-02-21
ATE222239T1 (de) 2002-08-15
ES2179857T3 (es) 2003-02-01
NO953204D0 (no) 1995-08-15
ZA956798B (en) 1996-03-19
CZ209095A3 (en) 1996-03-13
JP3860618B2 (ja) 2006-12-20
JPH0859621A (ja) 1996-03-05
PL310030A1 (en) 1996-02-19
SK100695A3 (en) 1996-06-05
FI953841L (fi) 1996-02-17
NO306296B1 (no) 1999-10-18
SI9500260A (en) 1996-02-29
AU710238B2 (en) 1999-09-16
DK0697405T3 (da) 2002-12-16
NO953204L (no) 1996-02-19
TW407151B (en) 2000-10-01
IL114937A0 (en) 1995-12-08
PT697405E (pt) 2002-12-31
FI953841A7 (fi) 1996-02-17
DE59510318D1 (de) 2002-09-19

Similar Documents

Publication Publication Date Title
CA2629461C (fr) Quinolones substituees et procedes d'utilisation
US5424311A (en) Azaquinoxalines and their use
US6069151A (en) Quinolines and their therapeutic use
Sridhar et al. Synthesis of quinoline acetohydrazide-hydrazone derivatives evaluated as DNA gyrase inhibitors and potent antimicrobial agents
EP2164828B1 (fr) Modulateurs des récepteurs crth2 et ou pgd2 et leur emploi pour traiter l'asthme et les inflammations d'origine allergique
CA3063111C (fr) Inhibiteurs des histone desacetylases (hdac)
EP3426652B1 (fr) Nouveaux inhibiteurs de la phosphatidylinositol 3-kinase gamma
EP1567112A2 (fr) Nouveaux composes chimiques
ZA200505523B (en) Asthma and allergic inflammation modulators
KR100245138B1 (ko) 퀴녹살린,이의 제조방법 및 이를 함유하는 약제학적 조성물
KR20100097156A (ko) 사람 면역결핍 바이러스 복제의 억제제
CA2268126A1 (fr) Quinoleines et leur utilisation therapeutique
JP4231107B2 (ja) 抗ウイルス作用を有する置換キノリン誘導体
US5602146A (en) 4-iminoquinolines, processes for their preparation, and their use
JP3860618B2 (ja) 置換キノリン誘導体、それらの製造方法およびそれらの使用
NZ280258A (en) Quinoxaline derivatives; preparative method and medicaments
KR900006745B1 (ko) 5-아미노-1,2-디티올-3-온 화합물 및 그의 제법
GB2282808A (en) 3-substituted heterocyclic indoles as inhibitors of HIV reverse transcriptase
WO1998035939A1 (fr) Derives de diamide malonique et utilisation de ces derniers
WO2023085392A1 (fr) Médicament contre le sars-cov-2
JPH10310576A (ja) イソキノリンスルフォンアミド誘導体及びこれを有効成分とする医薬
JPH0114224B2 (fr)
MXPA98009740A (en) Quinoline carboxamides as fnt inhibitors and as fde inhibitors

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected